Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Lin

Showing results (91-100 of 480) with videos related to

Pageof 48
Sort By:
Drug Metabolism Reviews|January 1, 1982
Pharmacokinetic consequences and toxicologic implications of endogenous cosubstrate depletionG Levy, R E Galinsky, J H Lin
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Potent and selective inactivation of human liver microsomal cytochrome P-450 isoforms by L-754,394, an investigational human immune deficiency virus protease inhibitorM Chiba, J A Nishime, J H Lin
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1978
Correlation between in vitro and in vivo drug metabolism rate: oxidation of ethoxybenzamide in ratJ H Lin, M Hayashi, S Awazu, et al.
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1982
Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological dataJ H Lin, Y Sugiyama, S Awazu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1991
Species-dependent stereopharmacokinetics of MK-927, a potent carbonic anhydrase inhibitorJ H Lin, I W Chen, T H Lin
Biomaterials|October 6, 1999
Effect of particle configuration on structure and properties of dispersed Pd-containing dental amalgamK I Chen, C P Ju, J H Lin
Biopharmaceutics & Drug Disposition|August 10, 1999
Renal handling of biphosphonate alendronate in ratsI Kino, Y Kato, J H Lin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1985
Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. I. An application of pharmacokinetic model for reversible metabolismJ H Lin, K C Yeh, D E Duggan
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1994
Nonlinear kinetics of alendronate. Plasma protein binding and bone uptakeJ H Lin, I W Chen, F A deLuna
Pharmaceutical Research|May 1, 1991
Dose-dependent pharmacokinetics of MK-417, a potent carbonic anhydrase inhibitor, in experimental polycythemic and anemic ratsJ H Lin, I W Chen, F A deLuna
Pageof 48

Showing results (91-100 of 480) with videos related to

Sort By:
Pageof 48
Drug Metabolism Reviews|January 1, 1982
Pharmacokinetic consequences and toxicologic implications of endogenous cosubstrate depletionG Levy, R E Galinsky, J H Lin
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Potent and selective inactivation of human liver microsomal cytochrome P-450 isoforms by L-754,394, an investigational human immune deficiency virus protease inhibitorM Chiba, J A Nishime, J H Lin
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1978
Correlation between in vitro and in vivo drug metabolism rate: oxidation of ethoxybenzamide in ratJ H Lin, M Hayashi, S Awazu, et al.
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1982
Physiological pharmacokinetics of ethoxybenzamide based on biochemical data obtained in vitro as well as on physiological dataJ H Lin, Y Sugiyama, S Awazu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1991
Species-dependent stereopharmacokinetics of MK-927, a potent carbonic anhydrase inhibitorJ H Lin, I W Chen, T H Lin
Biomaterials|October 6, 1999
Effect of particle configuration on structure and properties of dispersed Pd-containing dental amalgamK I Chen, C P Ju, J H Lin
Biopharmaceutics & Drug Disposition|August 10, 1999
Renal handling of biphosphonate alendronate in ratsI Kino, Y Kato, J H Lin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1985
Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. I. An application of pharmacokinetic model for reversible metabolismJ H Lin, K C Yeh, D E Duggan
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1994
Nonlinear kinetics of alendronate. Plasma protein binding and bone uptakeJ H Lin, I W Chen, F A deLuna
Pharmaceutical Research|May 1, 1991
Dose-dependent pharmacokinetics of MK-417, a potent carbonic anhydrase inhibitor, in experimental polycythemic and anemic ratsJ H Lin, I W Chen, F A deLuna
Pageof 48